SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells

BMP9 is a cytokine involved in the maturation phase of the angiogenic process that signals through its serine/threonine receptor ALK1 and its coreceptor endoglin. In this paper, we explain how BMP9 directs the regulation of endothelial cell proliferation blockage while in turn stimulating protein synthesis. To achieve this, BMP9 promotes SGK1 synthesis and activation through mTORC2 in order to stimulate the mTORC1/S6K/S6 axis. Moreover, BMP9 blocks proliferation also through SGK1 by reducing the activity of the MEK/ERK signalling pathway. Inhibition of SGK1 activity is sufficient to prevent BMP9‐mediated inhibition of ERK, leading to an increase in endothelial cell proliferation. Overall, our findings reveal that SGK1 is a key player during angiogenesis, mediating the pro‐quiescent and maturation effects of BMP9/ALK1.

[1]  S. Dupuis-Girod,et al.  Future treatments for hereditary hemorrhagic telangiectasia , 2020, Orphanet Journal of Rare Diseases.

[2]  A. Figueras,et al.  PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1 , 2019, Cells.

[3]  K. Guan,et al.  mTOR as a central hub of nutrient signalling and cell growth , 2019, Nature Cell Biology.

[4]  A. Burlingame,et al.  Phosphorylation at distinct subcellular locations underlies specificity in mTORC2-mediated activation of SGK1 and Akt , 2019, Journal of Cell Science.

[5]  B. Larrivée,et al.  BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Koichi Nishiyama,et al.  Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells , 2018, Angiogenesis.

[7]  X. Matías-Guiu,et al.  ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[8]  N. Katsanis,et al.  Endoglin interacts with VEGFR2 to promote angiogenesis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Cristofano.  SGK1: The Dark Side of PI3K Signaling. , 2017 .

[10]  A. Hinck,et al.  ALK1 signaling in development and disease: new paradigms , 2017, Cellular and Molecular Life Sciences.

[11]  Nanae Izumi,et al.  Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells , 2017, Biology Open.

[12]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[13]  W. Sessa,et al.  PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia , 2016, Nature Communications.

[14]  S. Chandarlapaty,et al.  PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition , 2016, Cancer cell.

[15]  R. Loewith,et al.  TORC2 Structure and Function. , 2016, Trends in biochemical sciences.

[16]  David Kaluza,et al.  VEGF, Notch and TGFβ/BMPs in regulation of sprouting angiogenesis and vascular patterning. , 2014, Biochemical Society transactions.

[17]  Dario R. Alessi,et al.  Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors , 2013, The Biochemical journal.

[18]  C. Mummery,et al.  Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. , 2012, Developmental cell.

[19]  A. Eichmann,et al.  ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. , 2012, Developmental cell.

[20]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[21]  N. Rosenthal,et al.  Serum and glucocorticoid‐inducible kinase 1 (SGK1) is necessary for vascular remodeling during angiogenesis , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  N. Ferrara,et al.  Targeting the tumour vasculature: insights from physiological angiogenesis , 2010, Nature Reviews Cancer.

[23]  C. Betsholtz,et al.  Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Alitalo,et al.  Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.

[25]  J. Blenis,et al.  RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.

[26]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[27]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[28]  P. Cohen,et al.  Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. , 2004, The Biochemical journal.

[29]  G. Corthals,et al.  Akt Mediates Insulin-stimulated Phosphorylation of Ndrg2 , 2004, Journal of Biological Chemistry.

[30]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[31]  P. Cohen,et al.  Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms , 2001, Science's STKE.

[32]  C. Haft,et al.  Activation of Serum- and Glucocorticoid-induced Protein Kinase (Sgk) by Cyclic AMP and Insulin* , 2001, The Journal of Biological Chemistry.

[33]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[34]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[35]  K. Walsh,et al.  Regulation of cdk2 activity in endothelial cells that are inhibited from growth by cell contact. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[36]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[37]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[38]  N. Katsanis,et al.  Endoglin interacts with VEGFR 2 to promote angiogenesis , 2018 .

[39]  A. Di Cristofano.  SGK1: The Dark Side of PI3K Signaling. , 2017, Current topics in developmental biology.

[40]  L. David,et al.  Identification of BMP 9 and BMP 10 as functional activators of the orphan activin receptor-like kinase 1 ( ALK 1 ) in endothelial cells , 2007 .

[41]  S. P. Herbert,et al.  Cytosolic phospholipase A2-alpha mediates endothelial cell proliferation and is inactivated by association with the Golgi apparatus. , 2005, Molecular biology of the cell.